Literature DB >> 1657063

Oxidative inactivation of alpha 1-proteinase inhibitor by alveolar macrophages from healthy smokers requires the presence of myeloperoxidase.

B Wallaert1, B Gressier, C Aerts, C Mizon, C Voisin, J Mizon.   

Abstract

The aim of this work was to study the ability of human alveolar macrophages (AM) of 10 healthy smokers to inactivate alpha 1-proteinase inhibitor (alpha 1PI). Purified alpha 1PI was incubated for 45 min, with human alveolar macrophages before and after stimulation by phorbol myristate acetate (PMA) or opsonized zymosan. As a positive control, the same experiments were performed in parallel with blood human neutrophils (PMN). Results are expressed as percentage of inactivation of alpha 1PI as evaluated from its inhibitory activity against porcine pancreatic elastase. A strong correlation (r = 0.99) was shown when inhibitory activity of alpha 1PI was evaluated against porcine pancreatic elastase or human neutrophil elastase. Unstimulated AM (1.57 +/- 0.9%) as well as stimulated AM (PMA: 1 +/- 0.4%; zymosan: 3 +/- 0.6%) were unable to inactivate alpha 1PI. Gel electrophoresis of alpha 1PI demonstrated that AM before or after stimulation induced a slight proteolysis of alpha 1PI, whereas both cleaved and complexed alpha 1PI were found when alpha 1PI was incubated with activated PMN. Both unstimulated (22 +/- 2.6%) and activated PMN (PMA: 91.7 +/- 4.7%; zymosan: 90 +/- 5.5%) were responsible for a significant inactivation of alpha 1PI. Catalase, in contrast to superoxide dismutase, was responsible for a near complete protection of alpha 1PI inactivation by PMN. To better determine the role of PMN secretory products, especially myeloperoxidase (MPO), we also investigated the effect of zymosan-activated PMN supernatants or of purified MPO on the alpha 1PI-AM reaction. MPO assay in PMN supernatants demonstrated that activated neutrophils released significant amounts of MPO (16.8 +/- 4.1 U/ml), whereas MPO was undetectable in activated AM supernatants.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1657063     DOI: 10.1165/ajrcmb/5.5.437

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  5 in total

1.  Presence, activities, and molecular forms of cathepsin G, elastase, alpha 1-antitrypsin, and alpha 1-antichymotrypsin in bronchiectasis.

Authors:  R Sepper; Y T Konttinen; T Ingman; T Sorsa
Journal:  J Clin Immunol       Date:  1995-01       Impact factor: 8.317

2.  Recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) or tumour necrosis factor-alpha (TNF-alpha) activate human alveolar macrophages to inhibit growth of Mycobacterium avium complex.

Authors:  K Suzuki; W J Lee; T Hashimoto; E Tanaka; T Murayama; R Amitani; K Yamamoto; F Kuze
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

3.  Relationship between bronchoalveolar lavage neutrophil numbers and lavage fluid elastase and antielastase activities.

Authors:  G Dent; K F Rabe; H Magnussen
Journal:  Lung       Date:  1995       Impact factor: 2.584

4.  Effects of 3'-hydroxyfarrerol (IdB 1031), a novel flavonoid agent, on phagocyte products.

Authors:  F Meloni; P Ballabio; M Gorrini; M De Amici; C Marena; S Malandrino; M Luisetti
Journal:  Inflammation       Date:  1995-12       Impact factor: 4.092

5.  Interactions of P 1507, a new antioxidant agent, with phagocyte functions.

Authors:  F Meloni; P Ballabio; G Leo; M Gorrini; S Manzardo; G Coppi; M Luisetti
Journal:  Agents Actions       Date:  1994-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.